Storia in 4 fonti

'Bariatric Surgery-Level' Weight Loss With Novel Triple-Agonist

Primary endpoints met in knee osteoarthritis and obstructive sleep apnea, too

Raccontata dahealio.commorningstar.comindependent.co.ukmedpagetoday.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 mesi fa

'Bariatric Surgery-Level' Weight Loss With Novel Triple-Agonist

Primary endpoints met in knee osteoarthritis and obstructive sleep apnea, too

originale

morningstar.com1 mesi fa

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain,…

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

Leggi questa versione → originale

healio.com1 mesi fa

Retatrutide benefits in obesity, type 2 diabetes ‘quite staggering’

NEW ORLEANS —A triple receptor agonist provided weight loss for adults with obesity, with or without type 2 diabetes, to an extent not seen with previous pharmacotherapy options, according to data from two phase 3…

Leggi questa versione → originale

independent.co.uk1 mesi fa

Eli Lilly’s new weight loss drug may also help sleep apnea according to Phase 3 data

The same trial also revealed retatrutide could offer substantial relief for knee osteoarthritis pain, reducing it by up to 73.1%

Leggi questa versione → originale

Timeline cronologica

1. sabato 6 giugno 2026·healio.com
   

   Retatrutide benefits in obesity, type 2 diabetes ‘quite staggering’

   NEW ORLEANS —A triple receptor agonist provided weight loss for adults with obesity, with or without type 2 diabetes, to an extent not seen with previous pharmacotherapy options,…

2. sabato 6 giugno 2026·morningstar.com
   

   Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea,…

   Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential…

3. sabato 6 giugno 2026·morningstar.com
   

   Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

   Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

4. sabato 6 giugno 2026·independent.co.uk
   

   Eli Lilly’s new weight loss drug may also help sleep apnea according to Phase 3 data

   The same trial also revealed retatrutide could offer substantial relief for knee osteoarthritis pain, reducing it by up to 73.1%

5. domenica 7 giugno 2026·medpagetoday.com
   

   'Bariatric Surgery-Level' Weight Loss With Novel Triple-Agonist

   Primary endpoints met in knee osteoarthritis and obstructive sleep apnea, too